17 18 Extensively drug-resistant Klebsiella pneumoniae (XDR-KP) infections cause high mortality and 19 are disseminating globally. Identifying the genetic basis underpinning resistance allows for rapid 20 diagnosis and treatment. XDR isolates sourced from Greece and Brazil, including nineteen 21 polymyxin-resistant and five polymyxin-susceptible strains, underwent whole genome 22 sequencing. Approximately 90% of polymyxin resistance was enabled by alterations upstream or 23 within mgrB. The most common mutation identified was an insertion at nucleotide position 75 in 24 mgrB via an ISKpn26-like element in the ST258 lineage and ISKpn13 in one ST11 isolate. Three 25 strains acquired an IS1 element upstream of mgrB and another strain had an ISKpn25 insertion at 26 133 bp. Other isolates had truncations (C28STOP, Q30STOP) or a missense mutation (D31E) 27
INTRODUCTION 8
Variant detection 138 Alterations both in and flanking the genes pmrAB, phoPQ and mgrB were examined and sequence 139 reads of all strains were aligned to the assembly of 20_GR_12, a polymyxin-susceptible ST258 140 strain with the least number of contigs, using BWA-MEM [38] . The alignment was analyzed 141 through FreeBayes [39] to identify single nucleotide and small indel variation, using a diploid 142 analysis in order to identify potential heterogeneity. Sites with more than 20% of reads mapping 143 to the minor allele were considered potentially heterogeneous. The effects of variations were 144 determined by snpEff [40] . The impact on protein sequence was further confirmed by the Protein 145 Variation Effect Analyzer (PROVEAN) [41] . For the analysis of large chromosome changes, the 146 gene sequences including 300 bp flanking were extracted from the assemblies. A multiple 147 alignment of each gene was constructed from the pair-wise alignment to the longest gene sequence.
148
Insertion sequence element validation 149 ISFinder [42] was used for the identification of insertion sequence (IS) elements. To confirm 150 disruptive IS elements, mgrB was amplified with primers displayed in Table S1 via 2X Phusion 151 HF master mix (Invitrogen) under the following cycling conditions: 98 °C 10 seconds, 50 °C 30 152 seconds and 72 °C 60 seconds (35X). Amplicon identity was validated via Sanger sequencing.
153
Complementation assays 154 The contribution of variants to resistance was validated through complementation assays as 155 previously described [43] . Briefly, genes (Table S1) Two thirds of the Greece clinical strains were found to belong to ST258 and the remaining were 189 ST11, ST147 or ST383 (Table 1) . While 5_GR_13 and 6_GR_12 were both ST383, only 5_GR_13 190 was resistant to polymyxin. Among the two strains from Brazil, 11_BR_13 was ST437 and 191 12_BR_13 was ST11. 21_GR_13 had a profile previously undefined and has been newly 192 designated ST2401. Further cgMLST studies were conducted on the isolates using complete 193 assemblies of reference genomes for ST11 (HS11286), ST147 (MS6671) ST258 (NJST258_1, 194 11 NJST258_2) and KQ (ATCC 700603) ( Fig. 1 ). For the ST258 isolates, these were more similar to 195 NJST258_2 rather than NJST258_1. Within this cluster, 7_GR_13, 9_GR_12 and 24_GR_13 were 196 closely related (≤15 allelic changes). Similarly, grouped together were 2_GR_12 and 23_GR_12; 197 3_GR_13 and 22_GR_12; 13_GR_14 and 14_GR_14; and 18_GR_14 and 19_GR_14. In ST11, 198 16_GR_13 and 17_GR_14 harbored only 3 allele differences and the Brazilian isolate, 12_BR_13, 199 had 206 variants apparent. ST383 isolates 5_GR_13 and 6_GR_12 only exhibited 1 allele change. Single, multiple and heterogeneous mutations 217 Aberrations in genes commonly identified to confer polymyxin resistance in KP include mgrB, 218 phoPQ and pmrAB (Table 2) . Several non-synonymous mutations were identified across the 219 isolates however, not all were predicted to be deleterious (Table S3 ). ST383 contained several 220 mutations in pmrAB although only Q30STOP in polymyxin-resistant 5_GR_13 was predicted to 
Role of mgrB disruptions and presence of heteroresistance via complementation assays 232
Complementation of the WT gene elucidated the role of these mutations in resistance (Fig. 2 ).
233
Introduction of pTOPO-mgrB restored susceptibility in all resistant isolates with mgrB coding 234 mutations or upstream disruptions, with the exception of two strains heterogeneous for the mgrB 235 disruption and a pmrB coding mutation (13_GR_14 and 14_GR_14) ( Fig. 2a ). For these two 236 strains, pTOPO-mgrB restored susceptibility in zero of three 13_GR_14 colonies and one of three 237 14_GR_14 colonies. Transformation of 1 out of 3 colonies for both 13_GR_14 and 14_GR_14 238 strains with pTOPO-pmrB restored susceptibility ( Fig. 2d ) and mgrB amplification of these 239 13 colonies revealed an intact mgrB locus (data not shown). Colonies which were reverted on 240 complementation were further passaged 3 times with no antibiotic pressure in order to remove the 241 plasmid and discern if these mutations were contributing to resistance. After passaging, pTOPO-242 mgrB isolates harbored an MIC of ≥64 mg/L whilst pTOPO-pmrB colonies were 16 mg/L to 243 confirm two resistant populations in these samples. 23_GR_12 was also observed to have a 244 heterogeneous mgrB disruption but did not carry a corresponding pmrB mutation however, 245 harbored similar mutations to 2_GR_12 in phoPQ. Amplification of mgrB identified two of three 246 23_GR_12 transformed colonies contained the IS element disruption and were reverted to 247 susceptible upon complementation with pTOPO-mgrB.
248
Validation of resistance conferring mutations in phoQ 249 Strains 8_GR_13 and 9_GR_12 harbored a single mutation in phoQ potentially conferring 250 resistance ( Table 2) . When these isolates were transformed with pTOPO-phoQ, results remained 251 variable where a lack of growth was present in a susceptible range (MIC: ≤2 mg/L) however, 252 several wells containing high polymyxin B concentrations exhibited growth ( Fig. 2c ). To resolve 253 this, the mutated gene was introduced into a polymyxin-susceptible isolate, 20_GR_12, and 254 resistance was apparent ( Fig. 2e ).
255
Potential suppressor mutations in phoPQ 256 Several mutations co-segregating with disrupted mgrB were detected including phoP (P74L, 257 A95S), phoQ (N253T, V446G) and pmrB (T140P). Complementation of WT genes in these 258 isolates commonly facilitated a ≥2-fold increase in MIC with the exception of 10_GR_13, which 259 had an additional predicted neutral mutation in phoQ (A225T) ( Table S3 , Fig. 2b-d ). To evaluate 260 the potential influence of these mutations on polymyxin resistance, mutated genes were placed 261 14 into a strain only containing the mgrB IS element disruption, 7_GR_13 (Fig. 2f ). Complementation 262 of the mutant phoQ (N253T) decreased the MIC by 2-fold, potentially indicating a partial 263 suppressor mutation. Initially, the phoQ (V446G) mutation was anticipated to segregate with the 264 mgrB disrupted population in 13_GR_14 and 14_GR_14 however, when phoQ was amplified from 265 a colony reverted to susceptible via pTOPO-mgrB complementation, the WT phoQ was observed 266 (Fig. S3 ). The phoQ (V446G) mutation was successfully amplified from a 14_GR_14 colony 267 containing the pmrB (T158R) mutation and upon complementation in 7_GR_13, resulted in a 2-268 fold reduction in MIC. Although this mutation did not segregate with disrupted mgrB, it may act 269 as a partial suppressor mutation when a resistance conferring mutation is present in pmrB. 270 Mutations in phoP (P74L, A95S) reduced the MIC in 7_GR_13 by ≥4-fold which identifies these 271 as partial suppressor mutations. Complementation of mutant pmrB (T140P) into 7_GR_13 did not 272 lead to an observable corresponding reduction in MIC however, once transformed into 20_GR_12, 273 a 2-fold increase in MIC was apparent ( Fig. 2e ). Polymyxin resistance in XDR-KP is of grave concern given that this is a last-line antibiotic, and 278 is increasingly prevalent in countries such as Greece and Brazil [10, [12] [13] [14] 44] . We evaluated the including reports from Greece, Italy, France, Turkey and Colombia [8, 9, 45, 46] . The ISKpn26-285 like element resembled the same sequence from Greece isolates previously described [46] . We 286 identified that this mutation still persisted in 2014, after being first detected in 2012 [9] . Several isolates harboring ISKpn26-like element disrupted mgrB were accompanied by mutations 320 in phoPQ and/ or pmrB. These changes were present in ≥98% of reads to render the involvement 321 of heterogeneity unlikely. Once complemented, an increase in resistance was commonly recorded.
322
This potentially reflects partial suppressor mutations as strains which solely possessed this IS 323 element disruption commonly exhibited a heightened MIC of ≥64 mg/L. One variant segregating 324 with this disruption included pmrB T140P. This had formerly been identified in an ST258 lineage 325 but even when the resistant gene was complemented, the MIC increased by 2-fold but was not 326 defined as clinically resistant [21, 50] .
327
When mutated phoP or phoQ were introduced into the mgrB disrupted isolate, a reduction in MIC 
